Skip to content
10-Q

Quarterly Report

Phio Pharmaceuticals Corp PHIO

0001437749-25-034857

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 11, 2025 10.76M sh
Capex Q3 2025 · Sep 30, 2025 $12K
Capex Q3 2025 · Sep 30, 2024 $0
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$5.9M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$5.74M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $10.71M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $5.38M
Stockholders Equity Q3 2025 · Sep 30, 2025 $9.84M
Stockholders Equity Q3 2025 · Jun 30, 2025 $10.1M
Stockholders Equity Q3 2025 · Mar 31, 2025 $12.17M
Stockholders Equity Q3 2025 · Dec 31, 2024 $4.72M
Stockholders Equity Q3 2025 · Sep 30, 2024 $4.95M
Stockholders Equity Q3 2025 · Jun 30, 2024 $3.77M
Stockholders Equity Q3 2025 · Mar 31, 2024 $5.6M
Stockholders Equity Q3 2025 · Dec 31, 2023 $7.73M
Total Liabilities Q3 2025 · Sep 30, 2025 $1.67M
Total Liabilities Q3 2025 · Dec 31, 2024 $1.02M
Current Assets Q3 2025 · Sep 30, 2025 $11.49M
Current Assets Q3 2025 · Dec 31, 2024 $5.74M
Total Assets Q3 2025 · Sep 30, 2025 $11.51M
Total Assets Q3 2025 · Dec 31, 2024 $5.74M
Eps Basic Q3 2025 · Sep 30, 2025 −$0.44
Eps Basic Q3 2025 · Sep 30, 2025 −$1.30
Eps Basic Q3 2025 · Sep 30, 2024 −$1.54
Eps Basic Q3 2025 · Sep 30, 2024 −$8.23
Sga Expense Q3 2025 · Sep 30, 2025 $1.32M
Sga Expense Q3 2025 · Sep 30, 2025 $3.55M
Sga Expense Q3 2025 · Sep 30, 2024 $946K
Sga Expense Q3 2025 · Sep 30, 2024 $3.06M
Rd Expense Q3 2025 · Sep 30, 2025 $1.18M
Rd Expense Q3 2025 · Sep 30, 2025 $3.14M
Rd Expense Q3 2025 · Sep 30, 2024 $644K
Rd Expense Q3 2025 · Sep 30, 2024 $2.66M
Net Income Q3 2025 · Sep 30, 2025 −$2.39M
Net Income Q3 2025 · Sep 30, 2025 −$6.33M
Net Income Q3 2025 · Jun 30, 2025 −$2.17M
Net Income Q3 2025 · Mar 31, 2025 −$1.77M
Net Income Q3 2025 · Sep 30, 2024 −$1.52M
Net Income Q3 2025 · Sep 30, 2024 −$5.52M
Net Income Q3 2025 · Jun 30, 2024 −$1.85M
Net Income Q3 2025 · Mar 31, 2024 −$2.15M
Operating Income Q3 2025 · Sep 30, 2025 −$2.51M
Operating Income Q3 2025 · Sep 30, 2025 −$6.69M
Operating Income Q3 2025 · Sep 30, 2024 −$1.59M
Operating Income Q3 2025 · Sep 30, 2024 −$5.71M